Dana Point authorizes joining national opioid settlements, delegates city manager to sign future deals

The Dana Point City Council on Sept. 16 voted 5‑0 to authorize the city manager to execute necessary documents to join settlements in the national opioid litigation and to allocate the city’s share of settlement funds to Orange County for use.

Council reported the action as a closed‑session report‑out at the meeting’s start. The council motion — made by Council Member Frost and seconded by Mayor Pro Tem Gabbard — authorized joining settlements with Purdue Pharma and the Sackler family and with several pharmaceutical manufacturers and distributors identified in the national litigation, and it delegated authority to the city manager to execute future similar settlements on substantially similar terms.

The settlements named in the city’s action, as read into the record, include Purdue Pharma and related Sackler family settlements and agreements with Amneal Pharmaceuticals, Apotex Corp., Alvogen, Hikma Pharmaceuticals, Mylan, Sun Pharmaceutical Industries and Zydus Pharmaceuticals USA (as read at the meeting; transcript included variant spellings). The council directed the city manager to allocate the city’s share of any funds to the county for county‑level use.

The vote was recorded in the closed‑session report as 5‑0. The council also delegated authority to the city manager to execute documents necessary for the city to join future settlements in the national opioid litigation on substantially similar terms.

No additional financial allocations or programmatic uses were specified during the public portion of the meeting; the council report indicated the city’s share would be allocated to the county but did not detail an expenditure plan. The city will follow any settlement notices and county allocation procedures as they become available.